PsyMed Ventures is a $25m venture fund focused on cutting edge mental health treatments including psychedelic therapeutic, neurotechnology, precision psychiatry and digital therapeutics. PsyMed Ventures invests in pre-seed, seed and Series A round. A third of PsyMed's current portfolio companies are co-founded by female founders. PsyMed donates 4.19% (wink to Bicycle Day, the day LSD was invested) to indigenous communities and non-profits in psychedelics space.

★ Support this podcast ★